These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35711447)

  • 1. Serum Soluble Mediator Profiles and Networks During Acute Infection With Distinct DENV Serotypes.
    Coutinho-da-Silva MS; Sucupira PHF; Bicalho KA; Campi-Azevedo AC; Brito-de-Sousa JP; Peruhype-Magalhães V; Rios M; Teixeira-Carvalho A; Coelho-Dos-Reis JGA; Antonelli LRDV; de Rezende VB; de Melo FLR; Garcia CC; Silva-Andrade JC; da Costa-Rocha IA; Bastos MS; da Rocha LA; Silva VA; Ferreira EDS; Marinho EPM; Costa AG; Gomes MS; Amaral LR; Furtado ECDS; da Silva EVP; Ramos BA; Dos Santos ÉB; Freitas MNO; Vasconcelos PFDC; Martins-Filho OA; Araújo MSS; Ferreira MS; Martins LC
    Front Immunol; 2022; 13():892990. PubMed ID: 35711447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype-associated immune response and network immunoclusters in children and adults during acute Dengue virus infection.
    Henrique Ferreira Sucupira P; Silveira Ferreira M; Santos Coutinho-da-Silva M; Alves Bicalho K; Carolina Campi-Azevedo A; Pedro Brito-de-Sousa J; Peruhype-Magalhães V; Rios M; Konduru K; Teixeira-Carvalho A; Grazziela Alves Coelho-Dos-Reis J; Ribeiro do Valle Antonelli L; Bortolo de Rezende V; Ludolf Ribeiro de Melo F; Couto Garcia C; Carla Silva-Andrade J; Artur da Costa-Rocha I; Alves da Rocha L; Aprigio Silva V; Damasceno Pinto S; Araújo de Melo S; Guimarães Costa A; de Souza Gomes M; Rodrigues Amaral L; Luiz Lima Bertarini P; Cristina da Silva Furtado E; Vieira Pinto da Silva E; Alves Ramos B; Barros Dos Santos É; Nazaré Oliveira Freitas M; Maria Caetano Faria A; Fernando da Costa Vasconcelos P; de Souza Bastos M; Carício Martins L; Assis Martins-Filho O; Sobreira Silva Araújo M
    Cytokine; 2023 Sep; 169():156306. PubMed ID: 37542834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection.
    Lai SC; Huang YY; Shu PY; Chang SF; Hsieh PS; Wey JJ; Tsai MH; Ben RJ; Hsu YM; Fang YC; Hsiao ML; Lin CC
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 30971466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections.
    Qiu LW; Di B; Wen K; Wang XS; Liang WH; Wang YD; Pan YX; Wang M; Ding YQ; Che XY
    Clin Vaccine Immunol; 2009 Jan; 16(1):88-95. PubMed ID: 19020106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.
    Gallichotte EN; Widman DG; Yount BL; Wahala WM; Durbin A; Whitehead S; Sariol CA; Crowe JE; de Silva AM; Baric RS
    mBio; 2015 Oct; 6(5):e01461-15. PubMed ID: 26463165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
    Zidane N; Dussart P; Bremand L; Bedouelle H
    BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
    VanBlargan LA; Milutinovic PS; Goo L; DeMaso CR; Durbin AP; Whitehead SS; Pierson TC; Dowd KA
    J Virol; 2021 Nov; 95(23):e0095621. PubMed ID: 34549976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
    Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
    J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.
    Dalrymple NA; Cimica V; Mackow ER
    mBio; 2015 May; 6(3):e00553-15. PubMed ID: 25968648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection.
    Auerswald H; Kann S; Klepsch L; Hülsemann J; Rudnik I; Schreiber S; Buchy P; Schreiber M
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of Rosmarinic Acid Against Four Serotypes of Dengue Virus.
    Panchal R; Ghosh S; Mehla R; Ramalingam J; Gairola S; Mukherjee S; Chowdhary A
    Curr Microbiol; 2022 May; 79(7):203. PubMed ID: 35612625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.
    Elong Ngono A; Chen HW; Tang WW; Joo Y; King K; Weiskopf D; Sidney J; Sette A; Shresta S
    EBioMedicine; 2016 Nov; 13():284-293. PubMed ID: 27746192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1.
    Zambrana JV; Hasund CM; Aogo RA; Bos S; Arguello S; Gonzalez K; Collado D; Miranda T; Kuan G; Gordon A; Balmaseda A; Katzelnick L; Harris E
    medRxiv; 2023 Nov; ():. PubMed ID: 38077039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
    VanBlargan LA; Mukherjee S; Dowd KA; Durbin AP; Whitehead SS; Pierson TC
    PLoS Pathog; 2013; 9(12):e1003761. PubMed ID: 24348242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.
    Kyle JL; Balsitis SJ; Zhang L; Beatty PR; Harris E
    Virology; 2008 Oct; 380(2):296-303. PubMed ID: 18774583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka.
    Nadugala MN; Jeewandara C; Malavige GN; Premaratne PH; Goonasekara CL
    PLoS One; 2017; 12(6):e0178009. PubMed ID: 28582388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
    Andrade DV; Katzelnick LC; Widman DG; Balmaseda A; de Silva AM; Baric RS; Harris E
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus.
    Kostyuchenko VA; Chew PL; Ng TS; Lok SM
    J Virol; 2014 Jan; 88(1):477-82. PubMed ID: 24155405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.